Can Özen
Impact in
- Molecular Medicine top 10%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA and protein synthesis mechanisms 5
- Cancer therapeutics and mechanisms 3
- Biochemical and Molecular Research 3
-
- HIV/AIDS drug development and treatment 4
- Co-authors
- Engin H. Serpersu (10 shared papers)Havva Yağcı Acar (3 shared papers)Adnan Kurt (1 shared paper)M. Natali Çizmeciyan (1 shared paper)Alphan Sennaroğlu (1 shared paper)Dilek Keskin (3 shared papers)Ayşen Tezcaner (3 shared papers)Yanuar Dwi Putra Limasale (1 shared paper)
- Journals
- Biochemistry (4 papers)Journal of Materials Chemistry (2 papers)International Journal of Pharmaceutics (2 papers)Journal of Chromatography A (2 papers)Microporous and Mesoporous Materials (1 paper)
- Partner nations
- TürkiyeUnited StatesSwitzerland
In The Last Decade
Can Özen
30 papers receiving 627 citations
Peers
Comparison fields: 5 of 96
- Molecular Medicine 42
- Biomaterials 90
- Microbiology 38
- Materials Chemistry 214
- Molecular Biology 275
Countries citing papers authored by Can Özen
This map shows the geographic impact of Can Özen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Özen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Özen more than expected).
Fields of papers citing papers by Can Özen
This network shows the impact of papers produced by Can Özen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Özen. The network helps show where Can Özen may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Özen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 137 | |
| 2 | 2015 | 51 | |
| 3 | 2005 | 47 | |
| 4 | 2004 | 37 | |
| 5 | 2009 | 36 | |
| 6 | 2018 | 35 | |
| 7 | 2014 | 33 | |
| 8 | 2011 | 27 | |
| 9 | 2022 | 24 | |
| 10 | 2006 | 24 | |
| 11 | 2010 | 23 | |
| 12 | 2012 | 23 | |
| 13 | 2007 | 21 | |
| 14 | 2019 | 21 | |
| 15 | 2017 | 15 | |
| 16 | 2017 | 14 | |
| 17 | 2018 | 14 | |
| 18 | 2007 | 13 | |
| 19 | 2014 | 13 | |
| 20 | 2018 | 7 |
About Can Özen
Can Özen is a scholar working on Molecular Biology, Infectious Diseases, Oncology, Physical and Theoretical Chemistry and Hematology, having authored 30 papers that have together received 644 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (5 papers), HIV/AIDS drug development and treatment (4 papers), thermodynamics and calorimetric analyses (4 papers), Quantum Dots Synthesis And Properties (3 papers), Antibiotic Resistance in Bacteria (3 papers), Cancer therapeutics and mechanisms (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Molecular Medicine (42 citations), Biomaterials (90 citations), Microbiology (38 citations), Materials Chemistry (214 citations) and Molecular Biology (275 citations). Can Özen has collaborated with scholars based in Türkiye, United States and Switzerland. Frequent co-authors include Engin H. Serpersu, Havva Yağcı Acar, Adnan Kurt, M. Natali Çizmeciyan, Alphan Sennaroğlu, Dilek Keskin, Ayşen Tezcaner, Yanuar Dwi Putra Limasale, Edward Wright and Sreeparna Banerjee. Their work appears in journals such as Biochemistry, Journal of Materials Chemistry, International Journal of Pharmaceutics, Journal of Chromatography A and Microporous and Mesoporous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.